Literature DB >> 22726472

Hemorrhoids detected at colonoscopy: an infrequent cause of false-positive fecal immunochemical test results.

Sietze T van Turenhout1, Frank A Oort, Jochim S Terhaar sive Droste, Veerle M H Coupé, Rene W van der Hulst, Ruud J Loffeld, Pieter Scholten, Annekatrien C T M Depla, Anneke A Bouman, Gerrit A Meijer, Chris J J Mulder, Leo G M van Rossum.   

Abstract

BACKGROUND: Colorectal cancer screening by fecal immunochemical tests (FITs) is hampered by frequent false-positive (FP) results and thereby the risk of complications and strain on colonoscopy capacity. Hemorrhoids might be a plausible cause of FP results.
OBJECTIVE: To determine the contribution of hemorrhoids to the frequency of FP FIT results.
DESIGN: Retrospective analysis from prospective cohort study.
SETTING: Five large teaching hospitals, including 1 academic hospital. PATIENTS: All subjects scheduled for elective colonoscopy.
INTERVENTIONS: FIT before bowel preparation. MAIN OUTCOME MEASUREMENTS: Frequency of FP FIT results in subjects with hemorrhoids as the only relevant abnormality compared with FP FIT results in subjects with no relevant abnormalities. Logistic regression analysis to determine colonic abnormalities influencing FP results.
RESULTS: In 2855 patients, 434 had positive FIT results: 213 had advanced neoplasia and 221 had FP results. In 9 individuals (4.1%; 95% CI, 1.4-6.8) with an FP FIT result, hemorrhoids were the only abnormality. In univariate unadjusted analysis, subjects with hemorrhoids as the only abnormality did not have more positive results (9/134; 6.7%) compared with subjects without any abnormalities (43/886; 4.9%; P = .396). Logistic regression identified hemorrhoids, nonadvanced polyps, and a group of miscellaneous abnormalities, all significantly influencing false positivity. Of 1000 subjects with hemorrhoids, 67 would have FP results, of whom 18 would have FP results because of hemorrhoids only. LIMITATIONS: Potential underreporting of hemorrhoids; high-risk individuals.
CONCLUSIONS: Hemorrhoids in individuals participating in colorectal cancer screening will probably not lead to a substantial number of false-positive test results.
Copyright © 2012 American Society for Gastrointestinal Endoscopy. Published by Mosby, Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22726472     DOI: 10.1016/j.gie.2012.03.169

Source DB:  PubMed          Journal:  Gastrointest Endosc        ISSN: 0016-5107            Impact factor:   9.427


  12 in total

1.  Evaluation of Mucosal Healing in Ulcerative Colitis by Fecal Calprotectin Vs. Fecal Immunochemical Test.

Authors:  Shiho Takashima; Jun Kato; Sakiko Hiraoka; Asuka Nakarai; Daisuke Takei; Toshihiro Inokuchi; Yuusaku Sugihara; Masahiro Takahara; Keita Harada; Hiroyuki Okada; Takehiro Tanaka; Kazuhide Yamamoto
Journal:  Am J Gastroenterol       Date:  2015-03-31       Impact factor: 10.864

2.  Participant-Related Risk Factors for False-Positive and False-Negative Fecal Immunochemical Tests in Colorectal Cancer Screening: Systematic Review and Meta-Analysis.

Authors:  Clasine M de Klerk; Lisanne M Vendrig; Patrick M Bossuyt; Evelien Dekker
Journal:  Am J Gastroenterol       Date:  2018-08-29       Impact factor: 10.864

3.  Inverted Appendix in a Patient With Weakness and Occult Bleeding.

Authors:  Avilasha Sinha; SreyRam Kuy
Journal:  Fed Pract       Date:  2022-05-13

4.  Colorectal cancer screening with fecal immunochemical testing: a community-based, cross-sectional study in average-risk individuals in Nigeria.

Authors:  Olusegun I Alatise; Anna J Dare; Patrick A Akinyemi; Fatimah B Abdulkareem; Samuel A Olatoke; Gregory C Knapp; T Peter Kingham
Journal:  Lancet Glob Health       Date:  2022-07       Impact factor: 38.927

5.  Long-fragment DNA as a potential marker for stool-based detection of colorectal cancer.

Authors:  Yibo Zhang; Yutaka Suehiro; Yoshitaro Shindo; Kouhei Sakai; Shoichi Hazama; Shingo Higaki; Isao Sakaida; Masaaki Oka; Takahiro Yamasaki
Journal:  Oncol Lett       Date:  2014-10-24       Impact factor: 2.967

6.  Colorectal Cancer Screening Programme in Spain: Results of Key Performance Indicators After Five Rounds (2000-2012).

Authors:  Gemma Binefa; Montse Garcia; Núria Milà; Esteve Fernández; Francisco Rodríguez-Moranta; Núria Gonzalo; Llúcia Benito; Ana Clopés; Jordi Guardiola; Víctor Moreno
Journal:  Sci Rep       Date:  2016-01-20       Impact factor: 4.379

7.  Are Hemorrhoids Associated with False-Positive Fecal Immunochemical Test Results?

Authors:  Nam Hee Kim; Jung Ho Park; Dong Il Park; Chong Il Sohn; Kyuyong Choi; Yoon Suk Jung
Journal:  Yonsei Med J       Date:  2017-01       Impact factor: 2.759

8.  Blood free-circulating DNA testing by highly sensitive methylation assay to diagnose colorectal neoplasias.

Authors:  Yutaka Suehiro; Shinichi Hashimoto; Shingo Higaki; Ikuei Fujii; Chieko Suzuki; Tomomi Hoshida; Toshihiko Matsumoto; Yuko Yamaoka; Taro Takami; Isao Sakaida; Takahiro Yamasaki
Journal:  Oncotarget       Date:  2018-03-30

9.  Predictive Modeling of Colonoscopic Findings in a Fecal Immunochemical Test-Based Colorectal Cancer Screening Program.

Authors:  Jade Law; Anand Rajan; Harry Trieu; John Azizian; Rani Berry; Simon W Beaven; James H Tabibian
Journal:  Dig Dis Sci       Date:  2021-08-04       Impact factor: 3.487

Review 10.  Faecal immunochemical tests (FIT) can help to rule out colorectal cancer in patients presenting in primary care with lower abdominal symptoms: a systematic review conducted to inform new NICE DG30 diagnostic guidance.

Authors:  Marie Westwood; Shona Lang; Nigel Armstrong; Sietze van Turenhout; Joaquín Cubiella; Lisa Stirk; Isaac Corro Ramos; Marianne Luyendijk; Remziye Zaim; Jos Kleijnen; Callum G Fraser
Journal:  BMC Med       Date:  2017-10-24       Impact factor: 8.775

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.